Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.
about
Vaccine Adjuvants: from 1920 to 2015 and BeyondUpdate on Guillain-Barré syndromeGuillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in EuropeRisk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in GermanySafety of pandemic (H1N1) 2009 monovalent vaccines in taiwan: a self-controlled case series study.Guillain-Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States."First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs.Simulation study of the effect of influenza and influenza vaccination on risk of acquiring Guillain-Barré syndromeThe Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG).Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination.Assessing the safety of influenza vaccination in specific populations: children and the elderly.Quantifying the impact of time-varying baseline risk adjustment in the self-controlled risk interval design.A simulation study to compare three self-controlled case series approaches: correction for violation of assumption and evaluation of bias.Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.Lack of association of Guillain-Barré syndrome with vaccinations.Development and application of two semi-automated tools for targeted medical product surveillance in a distributed data network.Editorial: Innovations in Study Design-A Call for Creative Solutions.Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.
P2860
Q26783879-71E8A4CB-7B46-4511-8B59-A4F3FD3922BBQ28293098-025E9C62-C69D-44FC-B126-BB57AB1A19C2Q30351998-5B884194-6A82-46DD-A12E-9149986EC4F0Q30357675-F6900A61-39B9-40C0-A034-3310D8D281E8Q30362413-C05303A8-F9CC-472B-B7EA-4C9C109EC351Q30428839-FC59C715-FFE3-414D-BF9C-5427CB7822E6Q34271547-21F2CCEB-6254-435A-9A81-EFF89DFE7952Q34430193-B32B3DCB-D93A-405D-8D63-433A68C29088Q35037338-486ADFE2-A5AD-46A0-A875-D3CA567FB0E7Q36057541-4D97D915-D51D-4094-8A0B-B80408089E4DQ36902462-C2D1D36A-FBE4-49B7-89D5-A828CF004374Q38045920-03E341E4-E132-4429-969C-DA68967A6097Q40435214-E5C02466-92BA-4DC5-A555-2BE4C438B1E7Q44009931-FAC38861-8BEC-47B3-AD90-09FB4E24385BQ44475855-6AEFCE1E-FE36-4B6C-9F76-991661C32675Q45873093-DAF7C6B9-A4E4-47B1-BA74-09AA0312E4E0Q47369849-39A5C29E-238D-4712-8999-D03FB7FE2261Q50080237-E7C87EBA-4E5A-4BC4-AAFF-B58A67B66635Q51849672-0CC046B1-890D-48A2-B926-6CA8568C5C6C
P2860
Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Risk of confirmed Guillain-Bar ...... y Datalink Project, 2009-2010.
@en
type
label
Risk of confirmed Guillain-Bar ...... y Datalink Project, 2009-2010.
@en
prefLabel
Risk of confirmed Guillain-Bar ...... y Datalink Project, 2009-2010.
@en
P2093
P50
P356
P1476
Risk of confirmed Guillain-Bar ...... ty Datalink Project, 2009-2010
@en
P2093
Anthony A Amato
Bruce H Fireman
Claudia Vellozzi
Doreen T Ho
Edward A Belongia
Eric S Weintraub
Grace M Lee
Lingling Li
Matthew F Daley
Melisa Rett
P304
P356
10.1093/AJE/KWS195
P407
P577
2012-05-11T00:00:00Z